175 related articles for article (PubMed ID: 14666703)
1. Synthesis and in vitro evaluation of the phenylboric acid derivative entrapped lipiodol in boron neutron capture therapy for hepatoma.
Chou FI; Chung HP; Shieh MS; Huang CW; Chung RJ; Liu HM; Yang JY; Chi CW; Lin YC; Lui WY; Kai JJ
Anticancer Res; 2003; 23(5A):3955-63. PubMed ID: 14666703
[TBL] [Abstract][Full Text] [Related]
2. Biodistribution of phenylboric acid derivative entrapped lipiodol and 4-borono-2-18F-fluoro-L-phenylalanine-fructose in GP7TB liver tumor bearing rats for BNCT.
Liao AH; Chou FI; Kuo YC; Chen HW; Kai JJ; Chang CW; Chen FD; Hwang JJ
Appl Radiat Isot; 2010 Mar; 68(3):422-6. PubMed ID: 20056428
[TBL] [Abstract][Full Text] [Related]
3. Preparation and in vitro evaluation of B-lipiodol as a boron delivery agent for neutron capture therapy of hepatoma.
Chou FI; Lui WY; Wei YY; Chung RJ; Kai JJ; Chi CW
Anticancer Res; 1999; 19(3A):1759-64. PubMed ID: 10470112
[TBL] [Abstract][Full Text] [Related]
4. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric study of boron neutron capture therapy with borocaptate sodium (BSH)/lipiodol emulsion (BSH/lipiodol-BNCT) for treatment of multiple liver tumors.
Suzuki M; Sakurai Y; Masunaga S; Kinashi Y; Nagata K; Ono K
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):892-6. PubMed ID: 14967447
[TBL] [Abstract][Full Text] [Related]
6. Boron-lipiodol: a potential new drug for the treatment of liver tumors.
Lin WY; Chi CW; Ho YJ; Wu IC; Chung YT; Chen SD; Chou FI; Kai JJ; Lui WY; Chen TJ; Lin Y
Anticancer Res; 2002; 22(6C):3989-92. PubMed ID: 12553023
[TBL] [Abstract][Full Text] [Related]
7. Intra-arterial administration of sodium borocaptate (BSH)/lipiodol emulsion delivers B-10 to liver tumors highly selectively for boron neutron capture therapy: experimental studies in the rat liver model.
Suzuki M; Masunaga S; Kinashi Y; Nagata K; Sakurai Y; Nakamatsu K; Nishimura Y; Maruhashi A; Ono K
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):260-6. PubMed ID: 15093923
[TBL] [Abstract][Full Text] [Related]
8. Feasibility evaluation of neutron capture therapy for hepatocellular carcinoma using selective enhancement of boron accumulation in tumour with intra-arterial administration of boron-entrapped water-in-oil-in-water emulsion.
Yanagie H; Kumada H; Nakamura T; Higashi S; Ikushima I; Morishita Y; Shinohara A; Fijihara M; Suzuki M; Sakurai Y; Sugiyama H; Kajiyama T; Nishimura R; Ono K; Nakajima J; Ono M; Eriguchi M; Takahashi H
Appl Radiat Isot; 2011 Dec; 69(12):1854-7. PubMed ID: 21752660
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronan as carrier of carboranes for tumor targeting in boron neutron capture therapy.
Meo CD; Panza L; Capitani D; Mannina L; Banzato A; Rondina M; Renier D; Rosato A; Crescenzi V
Biomacromolecules; 2007 Feb; 8(2):552-9. PubMed ID: 17291079
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic efficacy for hepatocellular carcinoma by boric acid-mediated boron neutron capture therapy in a rat model.
Lin SY; Lin CJ; Liao JW; Peir JJ; Chen WL; Chi CW; Lin YC; Liu YM; Chou FI
Anticancer Res; 2013 Nov; 33(11):4799-809. PubMed ID: 24222116
[TBL] [Abstract][Full Text] [Related]
11. First attempt of boron neutron capture therapy (BNCT) for hepatocellular carcinoma.
Suzuki M; Sakurai Y; Hagiwara S; Masunaga S; Kinashi Y; Nagata K; Maruhashi A; Kudo M; Ono K
Jpn J Clin Oncol; 2007 May; 37(5):376-81. PubMed ID: 17578894
[TBL] [Abstract][Full Text] [Related]
12. Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy.
Dagrosa MA; Viaggi M; Rebagliati RJ; Batistoni D; Kahl SB; Juvenal GJ; Pisarev MA
Mol Pharm; 2005; 2(2):151-6. PubMed ID: 15804189
[TBL] [Abstract][Full Text] [Related]
13. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
[TBL] [Abstract][Full Text] [Related]
14. Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy.
Masunaga S; Nagasawa H; Hiraoka M; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
Anticancer Res; 2004; 24(5A):2975-83. PubMed ID: 15517904
[TBL] [Abstract][Full Text] [Related]
15. Suitability of boric acid as a boron drug for boron neutron capture therapy for hepatoma.
Hung YH; Lin YC; Lin YT; Shih GW; Liao JW; Chen KS; Liu HM; Chen YW; Chuang YJ; Yang CM; Peir JJ; Yang CH; Chou FI
Appl Radiat Isot; 2020 Oct; 164():109254. PubMed ID: 32554126
[TBL] [Abstract][Full Text] [Related]
16. Boron analysis and boron imaging in biological materials for Boron Neutron Capture Therapy (BNCT).
Wittig A; Michel J; Moss RL; Stecher-Rasmussen F; Arlinghaus HF; Bendel P; Mauri PL; Altieri S; Hilger R; Salvadori PA; Menichetti L; Zamenhof R; Sauerwein WA
Crit Rev Oncol Hematol; 2008 Oct; 68(1):66-90. PubMed ID: 18439836
[TBL] [Abstract][Full Text] [Related]
17. Study on the compounds containing 19F and 10B atoms in a single molecule for the application to MRI and BNCT.
Hattori Y; Asano T; Niki Y; Kondoh H; Kirihata M; Yamaguchi Y; Wakamiya T
Bioorg Med Chem; 2006 May; 14(10):3258-62. PubMed ID: 16460951
[TBL] [Abstract][Full Text] [Related]
18. Selective boron delivery by intra-arterial injection of BSH-WOW emulsion in hepatic cancer model for neutron capture therapy.
Yanagie H; Dewi N; Higashi S; Ikushima I; Seguchi K; Mizumachi R; Murata Y; Morishita Y; Shinohara A; Mikado S; Yasuda N; Fujihara M; Sakurai Y; Mouri K; Yanagawa M; Iizuka T; Suzuki M; Sakurai Y; Masunaga SI; Tanaka H; Matsukawa T; Yokoyama K; Fujino T; Ogura K; Nonaka Y; Sugiyama H; Kajiyama T; Yui S; Nishimura R; Ono K; Takamoto S; Nakajima J; Ono M; Eriguchi M; Hasumi K; Takahashi H
Br J Radiol; 2017 Jun; 90(1074):20170004. PubMed ID: 28406315
[TBL] [Abstract][Full Text] [Related]
19. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H
J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412
[TBL] [Abstract][Full Text] [Related]
20. Selective uptake of p-boronophenylalanine by osteosarcoma cells for boron neutron capture therapy.
Ferrari C; Zonta C; Cansolino L; Clerici AM; Gaspari A; Altieri S; Bortolussi S; Stella S; Bruschi P; Dionigi P; Zonta A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S341-4. PubMed ID: 19394838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
